XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES
3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
LEASES LEASES
The Company leases real estate and manufacturing and laboratory equipment which are used in the Company’s manufacturing, research and development, and administrative activities. The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration. These arrangements are classified as finance leases and operating leases. Finance leases consist of laboratory and manufacturing equipment with remaining terms ranging from 1 year to 3 years. The Company’s operating leases relate to the Company’s manufacturing facilities and office space and have remaining terms from 7 years to 9 years.

Refer to the Company’s financial statements included in its 2021 10-K for further information on its lease arrangements. There were no new material leases entered into during the three months ended March 31, 2022.
The right-of-use assets and lease liabilities recognized on the Company’s balance sheet as of March 31, 2022 and December 31, 2021 were as follows:
Balance Sheet LocationMarch 31, 2022December 31, 2021
Assets
Right-of-use assets operating leasesOperating lease right-of-use assets$84,212 $79,474 
Right-of-use assets finance leasesProperty and equipment, net9,182 9,821 
Liabilities
Operating lease liabilities (current)Operating lease liabilities, current7,594 7,147 
Finance lease liabilities (current)Finance lease liabilities, current2,620 2,621 
Operating lease liabilities (non-current)Operating lease liabilities, net of current portion47,626 46,464 
Finance lease liabilities (non-current)Finance lease liabilities, net of current portion2,627 3,271 
The components of lease expense for the three months ended March 31, 2022 and 2021 were as follows:
Three Months Ended March 31,
20222021
Operating lease cost$2,762 $1,117 
Finance lease cost:
Amortization of right-of-use assets639 335 
Interest on lease liabilities51 49 
Total lease cost$3,452 $1,501 
LEASES LEASES
The Company leases real estate and manufacturing and laboratory equipment which are used in the Company’s manufacturing, research and development, and administrative activities. The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration. These arrangements are classified as finance leases and operating leases. Finance leases consist of laboratory and manufacturing equipment with remaining terms ranging from 1 year to 3 years. The Company’s operating leases relate to the Company’s manufacturing facilities and office space and have remaining terms from 7 years to 9 years.

Refer to the Company’s financial statements included in its 2021 10-K for further information on its lease arrangements. There were no new material leases entered into during the three months ended March 31, 2022.
The right-of-use assets and lease liabilities recognized on the Company’s balance sheet as of March 31, 2022 and December 31, 2021 were as follows:
Balance Sheet LocationMarch 31, 2022December 31, 2021
Assets
Right-of-use assets operating leasesOperating lease right-of-use assets$84,212 $79,474 
Right-of-use assets finance leasesProperty and equipment, net9,182 9,821 
Liabilities
Operating lease liabilities (current)Operating lease liabilities, current7,594 7,147 
Finance lease liabilities (current)Finance lease liabilities, current2,620 2,621 
Operating lease liabilities (non-current)Operating lease liabilities, net of current portion47,626 46,464 
Finance lease liabilities (non-current)Finance lease liabilities, net of current portion2,627 3,271 
The components of lease expense for the three months ended March 31, 2022 and 2021 were as follows:
Three Months Ended March 31,
20222021
Operating lease cost$2,762 $1,117 
Finance lease cost:
Amortization of right-of-use assets639 335 
Interest on lease liabilities51 49 
Total lease cost$3,452 $1,501